Capricor Therapeutics and CureDuchenne to Host Webinar on November 3, 2015 at 3:00 p.m. ET
29 oct. 2015 16h57 HE
|
Capricor Therapeutics, Inc.
LOS ANGELES, Oct. 29, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (Nasdaq:CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class...
Capricor Therapeutics to Present at 2015 Stem Cell Meeting on the Mesa
30 sept. 2015 16h00 HE
|
Capricor Therapeutics, Inc.
LOS ANGELES, Sept. 30, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ:CAPR) a biotechnology company focused on the discovery, development and commercialization of first-in-class...
Capricor Therapeutics Reports Second Quarter 2015 Business & Financial Highlights
13 août 2015 16h05 HE
|
Capricor Therapeutics, Inc.
LOS ANGELES, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ:CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class...
Capricor Therapeutics to Hold Second Quarter 2015 Business Update and Financial Results Conference Call on August 13, 2015 at 4:30 p.m. EDT
06 août 2015 08h00 HE
|
Capricor Therapeutics, Inc.
LOS ANGELES, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ:CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class...
Capricor Therapeutics Appoints Deborah Ascheim, M.D. as Chief Medical Officer
04 août 2015 08h00 HE
|
Capricor Therapeutics, Inc.
LOS ANGELES, Aug. 4, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (NASDAQ:CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class...
Capricor Therapeutics Appoints Houman Hemmati M.D., Ph.D. to Vice President of Medical and Clinical Development for New Therapies
17 juin 2015 08h00 HE
|
Capricor Therapeutics, Inc.
LOS ANGELES, June 17, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (Nasdaq:CAPR), a biotechnology company focused on the discovery, development and commercialization of first-in-class...
Capricor Therapeutics and CureDuchenne to Host Webinar on June 19, 2015 at 3:00 p.m. ET
15 juin 2015 08h00 HE
|
Capricor Therapeutics, Inc.
LOS ANGELES, June 15, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (Nasdaq:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases...
Capricor Announces Receipt of FDA Clearance for the Phase I/II Study of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy Related Cardiomyopathy
08 juin 2015 08h42 HE
|
Capricor Therapeutics, Inc.
LOS ANGELES, June 8, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (Nasdaq:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases,...
Capricor Therapeutics to Participate in Two Upcoming Investor Conferences in June
26 mai 2015 16h15 HE
|
Capricor Therapeutics, Inc.
LOS ANGELES, May 26, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (Nasdaq:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases,...
Capricor Therapeutics Reports First Quarter 2015 Financial & Business Highlights
12 mai 2015 16h01 HE
|
Capricor Therapeutics, Inc.
LOS ANGELES, May 12, 2015 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc. (Nasdaq:CAPR), a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases,...